AzTrials
AzTrials

Recruitment, Invitation Letters, Patients With SchizophreniaNCT03590015

Recruitment of Patients Through Invitation Letters

A study testing Old invitation letter and New invitation Letter in people with Recruitment, Invitation Letters, Patients With Schizophrenia, run by Aalborg University Hospital at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Recruitment of patients with schizophrenia to clinical trials is difficult and in an ongoing project different methods of recruitment have been used in order to recruit. One of the methods used have been sending potential participant to the study an invitation letter with information of the study and an invitation to… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Old invitation letter and New invitation Letter
Could I receive a placebo?
No, everyone receives an active treatment
How many people
84 participants
Where
1 siteDenmark
Study dates
1 Feb 2018to 1 Apr 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • >18 years
  • Patients with a diagnosis within the spectre of Schizophrenia (F-20 to F-25) for at least ten years
  • At the time of recruitment, a diagnosis of either F-20 or F-25 ( all diagnoses from ICD-10)
  • Recidency in the Northern part of Jutland
  • In treatment by an outpatient team
  • Low frequency of contact with a clinician, once a month at the most

Who cannot join

  • No exclusion criteria for receiving an invitation Letter

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Bettina Ellen Grønbech

    Aalborg, Northern Part of Jutland, 9000

Other trials in Denmark

About this study

Official title: Recruitment of Patients With Schizophrenia for "The Coronary Disease Project" Through Invitation Letters

Recruitment of patients with schizophrenia to clinical trials is difficult and in an ongoing project different methods of recruitment have been used in order to recruit. One of the methods used have been sending potential participant to the study an invitation letter with information of the study and an invitation to make contact with a project nurse. Not many patients have replied.

The aim of this study is to examine whether a simplified version of the invitation Letter, in terms of information structure and written style will encourage more patients to make contact to a project nurse.

Read the detailed description

It is found that patients suffering from Schizophrenia have a positive attitude concerning participation in a research project but this doesn't always lead to recruitment. This might be due to schizophrenia being a disease causing self-disturbances in communication and contact to the surrounding World. It may lead to vulnerability in decision-making an a lower decision making capacity. Language disability is one of the most notable cognitive deficits in patients suffering from Schizophrenia and can be devided in to main components of usage and comprehension. Patients experience poorer listening comprehension and reading comprehension with no correlation to either age or education level and studies have shown that patients with schizophrenia have low literacy.

Therefore the aim of this study is to examine whether a rewritten version of an invitation Letter, taking in consideration patients low literacy and therefore written in simple sentences and with a sequential structure of information will make more patients take contact to a project nurse compared to patients receiving the original invitation Letter. The study design is a randomized controlled trial testing the old letter against the new letter.

Being tested
Old invitation letter, New invitation Letter
Keywords
Recruitment, Invitation Letter, patients, Schizophrenia
Medical subject headings
Schizophrenia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Old invitation letterOther

    Invitation Letter written by researchers/doctors

  • New invitation LetterOther

    Invitation Letter written in simple sentences and a sequential structure of basic information in the rewritten information Letter

Study groups in NCT03590015
Study groupRoleWhat they receive
old letter of invitationOtherOld invitation letter written by researchers/doctors in "The coronary project" sent to patients in order to recruit to an ongoing project
Receives: Other: Old invitation letter
New letter of invitationOtherNew invitation Letter written with consideration of impaired language comprehension and has therefore been written in simple sentences with a sequential structure of basic information sent to patients in an ongoing project.
Receives: Other: New invitation Letter

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Response rates to the invitation Letters to be compared

    response made to project nurse either by E-mail or phone

    Measured: within 3 weeks from receiving an invitation Letter

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2018
  2. Study start1 Feb 2018
  3. Primary completion1 Mar 2018
  4. Study completion1 Apr 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
84 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03590015
Sponsor's protocol ID
Invitationsbrevet
Status last verified
Jul 2018
First submitted
6 Jul 2018
Last updated
24 Jul 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Old invitation letter and New invitation Letter in people with Recruitment, Invitation Letters, Patients With Schizophrenia, run by Aalborg University Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Response rates to the invitation Letters to be compared (time frame: within 3 weeks from receiving an invitation Letter). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in